427
Views
6
CrossRef citations to date
0
Altmetric
Author's View

Improved immunogenicity of fusions between ethanol-treated cancer cells and dendritic cells exposed to dual TLR stimulation

, , , , , , , , , , & show all
Article: e25375 | Received 08 Jun 2013, Accepted 12 Jun 2013, Published online: 01 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Abdelhabib Semlali, Narasimha Reddy Parine, Nouf S Al-Numair, Mikhlid Almutairi, Yousef M Hawsawi, Abdullah Al Amri, Abdulrahman M Aljebreen, Maha Arafah, Majid A Almadi, Nahla Ali Azzam, Othman Alharbi & Mohammad Saud Alanazi. (2018) Potential role of Toll-like receptor 2 expression and polymorphisms in colon cancer susceptibility in the Saudi Arabian population. OncoTargets and Therapy 11, pages 8127-8141.
Read now
Danlei Chen, Fengyun Zhang, Haifeng Ren, Jia Luo & Siying Wang. (2017) Role of cytokines and chemokines in alcohol-induced tumor promotion. OncoTargets and Therapy 10, pages 1665-1671.
Read now
Abdelhabib Semlali, Mikhlid Almutairi, Narasimha Reddy Parine, Abdullah Al Amri, Jilani P Shaik, Abdulrahman Al Naeem, Sana Abdulla Ajaj, Mahmoud Rouabhia & Mohammad Saud Alanazi. (2017) No genetic relationship between TLR2 rs4696480, rs3804100, and rs3804099 gene polymorphisms and female breast cancer in Saudi populations. OncoTargets and Therapy 10, pages 2325-2333.
Read now

Articles from other publishers (3)

Shigeo Koido. (2016) Dendritic-Tumor Fusion Cell-Based Cancer Vaccines. International Journal of Molecular Sciences 17:6, pages 828.
Crossref
Xin Wan, Ci Cheng, Zhe Lin, Runqiu Jiang, Wei Zhao, Xin Yan, Junwei Tang, Kun Yao, Beicheng Sun & Yun Chen. (2015) The attenuated hepatocellular carcinoma-specific Listeria vaccine Lmdd-MPFG prevents tumor occurrence through immune regulation of dendritic cells. Oncotarget 6:11, pages 8822-8838.
Crossref
Lorenzo Galluzzi, Erika Vacchelli, José-Manuel Bravo-San Pedro, Aitziber Buqué, Laura Senovilla, Elisa Elena Baracco, Norma Bloy, Francesca Castoldi, Jean-Pierre Abastado, Patrizia Agostinis, Ron N. Apte, Fernando Aranda, Maha Ayyoub, Philipp Beckhove, Jean-Yves Blay, Laura Bracci, Anne Caignard, Chiara Castelli, Federica Cavallo, Estaban Celis, Vincenzo Cerundolo, Aled Clayton, Mario P. Colombo, Lisa Coussens, Madhav V. Dhodapkar, Alexander M. Eggermont, Douglas T. Fearon, Wolf H. Fridman, Jitka Fučíková, Dmitry I. Gabrilovich, Jérôme Galon, Abhishek Garg, François Ghiringhelli, Giuseppe Giaccone, Eli Gilboa, Sacha Gnjatic, Axel Hoos, Anne Hosmalin, Dirk Jäger, Pawel Kalinski, Klas Kärre, Oliver Kepp, Rolf Kiessling, John M. Kirkwood, Eva Klein, Alexander Knuth, Claire E. Lewis, Roland Liblau, Michael T. Lotze, Enrico Lugli, Jean-Pierre Mach, Fabrizio Mattei, Domenico Mavilio, Ignacio Melero, Cornelis J. Melief, Elizabeth A. Mittendorf, Lorenzo Moretta, Adekunke Odunsi, Hideho Okada, Anna Karolina Palucka, Marcus E. Peter, Kenneth J. Pienta, Angel Porgador, George C. Prendergast, Gabriel A. Rabinovich, Nicholas P. Restifo, Naiyer Rizvi, Catherine Sautès-Fridman, Hans Schreiber, Barbara Seliger, Hiroshi Shiku, Bruno Silva-Santos, Mark J. Smyth, Daniel E. Speiser, Radek Spisek, Pramod K. Srivastava, James E. Talmadge, Eric Tartour, Sjoerd H. Van Der Burg, Benoît J. Van Den Eynde, Richard Vile, Hermann Wagner, Jeffrey S. Weber, Theresa L. Whiteside, Jedd D. Wolchok, Laurence Zitvogel, Weiping Zou & Guido Kroemer. (2014) Classification of current anticancer immunotherapies. Oncotarget 5:24, pages 12472-12508.
Crossref